Population
34 patients with a Heart Mate II continuous flow left ventricular assist device who underwent ventricular…
Design
Cohort
Follow-up
25±15 months
Authors
Loading...
Scar-focused ablation may be considered in LVAD VT; hypothesis-generating and leaves open need for randomized confirmation.
Catheter ablation of VT in patients with continuous flow LVADs is feasible and safe, with intrinsic myocardial scar being the dominant arrhythmogenic substrate rather than the device cannula.
Sacher et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: